Type-2 diabetes is among the fastest growing health concern worldwide, The Global Type-2 Diabetes market is anticipated to grow at an astronomical rate on account of booming ageing population, rising obesity rate in adults and escalating incidences of type-2 cases among people in developing and developed countries. According to the International Diabetes Federation, more than 317 million people have been diagnosed with diabetes, and an additional 187 million are living undiagnosed.
Based on age group, 20-65 age group segment dominated the global type-2 diabetes market in 2019 and is anticipated to maintain its dominance in the forecasted period. The burgeoning levels of obesity in children, adolescents, and younger adults, diminishing engagement in physical inactivity, and poor diet due to hectic lifestyle. According to ADA Journal Diabetes Care, number of people under the age of 20 with type 2 diabetes is expected to increase by up to 49 percent by 2050. However, the surging rates of incidence which escalate the number of type 2 cases in youth to quadruple. Hence, this is projected to promulgate the market growth in the forthcoming years.
Based on gender, women are anticipated to dominate the global type-2 diabetes market during 2020-25. The market growth is attribute to burgeoning risk of developing gestational diabetes in pregnant as a multiple adverse pregnancy outcome which would further develop into type-2 diabetes. According to IDF, half of women with a history of GDM go on to develop type 2 diabetes within five to ten years after delivery. Thus, it is anticipated to boost the market growth of the type-2 diabetes in the forecasted period.
Asia-pacific region is expected to have higher number of type-2 patient in the forthcoming period owing to the increasing obesity rate in the country such as India, growing aged population, high sugar exposure and sedentary lifestyle of people. Type-2 prevalence has been growing fastest in China. Moreover, the prevalence of overweight and obesity is estimated to remain higher India especially in urban areas, with 32.3% respectively among urban women and 37.1% among urban men by 2040.
The key players with a considerable market share in the Global Type-2 Diabetes market are Merck & Co, AstraZeneca, Novo Nordisk. Bristol-Myers Squibb, Eli Lilly, Sanofi, Boehringer Ingelheim, Pfizer, Takeda, Biocon, Johnson & Johnson etc.












